Do you think the rand weakness actually helps APN's export margins or does it just get eaten by input costs…by @cape_steel on $APN

Do you think the rand weakness actually helps APN's export margins or does it just get eaten by input costs. The whole emerging market pharma play feels stretched at R144.74 unless they're growing revenue offshore, which I haven't seen in the results.